SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-24
👔
Seaport Therapeutics, Inc.
@SPTX_InsiderForm 4 Filing: HOMBACH ROBERT J. Buys $235,768 of $SPTX
INSIDER PURCHASE
⚡ MATERIALITY: 6/10
corporate issuer
Seaport Therapeutics, Inc.
Ticker: $SPTX
Transaction Value
$235,768
Price/Share: $18.14
transaction date
2026-06-22
Shares: 13,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, HOMBACH ROBERT J., holds the title of Director at Seaport Therapeutics, Inc..
On 2026-06-22, the insider transacted 13,000 shares.The shares were transacted at a weighted average price of $18.14 per share, resulting in a total market-relevant value of $235,768.
Executive Summary Summary
HOMBACH ROBERT J. (Director) bought $236K of $SPTX
Post-Transaction Position: 13,000 shares
SEC Accession No: 0001193125-26-280175 (CIK: 1496182)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.